Evidence map›Paper›PMID 34394364›Full record

ReviewTanaffos2021

A Systematic Review and Meta-Analysis of Prevalence of Obstructive Sleep Apnea in Iranian Patients with Cardiovascular Disease: Perspective of Prevention, Care and Treatment.

Mahboubeh Farasat, Hero Khwrshid Hassan, Niloufar Mirzaei, Ali Hasanpour Dehkordi, Reza Ghanei Gheshlagh

Abstract readReview
In one paragraph

Review in Tanaffos, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahboubeh FarasatDepartment of Nursing, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Hero Khwrshid HassanDepartment of English, College of Education, Bayan University, Erbil, Kurdistan, Iraq.
Niloufar MirzaeiShahid Rahimi's Hospital of Khoramabad, Lorestan University of Medical Sciences, Khoramabad, Iran.
Ali Hasanpour DehkordiSocial Determinants of Health Research Center, School of Allied Medical Sciences, Shahrekord University of Medical sciences, Shahrekord, Iran.
Reza Ghanei GheshlaghSpiritual Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObstructive sleep apnea (OSA) is a chronic breathing disorder during sleep. It is prevalent among patients with cardiovascular disease (CVD) and can increase its severity and mortality. Various studies have reported different results in Iran. This systematic review and meta-analysis aimed to determine the prevalence of OSA in Iranian patients with CVD. MATERIALS AND

methodsIn this study, eight papers published in Persian and English languages were reviewed. The articles were searched using the following keywords and all their possible combinations: "obstructive sleep apnea", "sleep-disordered breathing", "sleep apnea", "OSA", "cardiovascular disease", "hypertension", and "Iran". Scientific databases, including the Scientific Information Database (SID), Magiran, Web of Science, PubMed, and Scopus, were searched with no time limitations. Data were analyzed using a meta-analysis and a random effects model. Besides, heterogeneity was assessed using the I

resultsThe review of eight studies, with a total sample size of 1646 patients, showed that the prevalence of OSA was 59.21% (95% CI: 53.11-65.32) among CVD patients. Also, the prevalence of OSA was higher in men (60.12%; 95% CI: 60.12-82.54) than in women (41.01%; 95% CI: 16.08-65.94). Besides, it was estimated to be higher based on the STOP and STOP-BANG questionnaires (63%; 95% CI: 52.89-73.10) as compared to the Berlin questionnaire (56.63%; 95% CI: 49.20-64.06).

conclusionMore than half of Iranian CVD patients have OSA. Therefore, identifying high-risk patients to reduce the adverse effects of sleep apnea seems necessary.

Indexed as

Cardiovascular diseaseObstructive sleep apneaSystematic review

Identifiers

PMID34394364
PMCPMC8355939

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.